<--- Back to Details
First PageDocument Content
Business / Economy / Biotechnology / American brands / Specialty drugs / CAC 40 / Sanofi / Biosimilar / Biopharmaceutical / Janssen Biotech / Fine chemical / Johnson & Johnson
Date: 2016-06-01 15:33:28
Business
Economy
Biotechnology
American brands
Specialty drugs
CAC 40
Sanofi
Biosimilar
Biopharmaceutical
Janssen Biotech
Fine chemical
Johnson & Johnson

Add to Reading List

Source URL: www.dcat.org

Download Document from Source Website

File Size: 300,36 KB

Share Document on Facebook

Similar Documents

PDF Document

DocID: 1vWaT - View Document

Press release Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi 

DocID: 1vq21 - View Document

Press release Ipsen completes acquisition of select Consumer Healthcare products from Sanofi Paris (France), 8 May 2017 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced that it has completed its previously announce

DocID: 1vnbG - View Document

SANOFI WELCOMES House Policy Coucus KEY FACTS & FIGURES sANoFt

DocID: 1v7jN - View Document

A GLOBAL HEALTHCARE COMPANY We are Sanofi CORPORATE PRESENTATION | JUNE

DocID: 1uQ20 - View Document